Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice
IUBMB Life · 2024
DOI: 10.1002/iub.2857 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Xinyi Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, Osteoclasts, Bone Density. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Higher Education Discipline Innovation Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoporosis (OP) is a systemic metabolic bone disease resulting in reduced bone strength and increased susceptibility to fractures, making it a significant public health and economic problem worldwide. The clinical use of anti‐osteoporosis agents is limited because of their serious side effects or the high cost of long‐term use. The Xianlinggubao (XLGB) formula is an effective traditional Chinese herbal medicine commonly used in orthopedics to treat osteoporosis; however, its mechanism of action remains unclear. In this study, we screened 40 small RNAs derived from XLGB capsules and found that XLGB28‐sRNA targeting TNFSF11 exerted a significant anti‐osteoporosis effect in vitro and in vivo by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis. Oral administration of bencaosome [16:0 Lyso PA+XLGB28‐sRNA] effectively improved bone mineral density and reduced the damage to the bone microstructure in mice. These results suggest that XLGB28‐sRNA may be a novel oligonucleotide drug that promotes osteogenesis and inhibits osteoclastogenesis in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical Co…
- Department of Orthopaedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
ORCID-Profile: Chengyu Jiang
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- Higher Education Discipline Innovation Project
- National Natural Science Foundation of China
- State Key Laboratory Special Fund
- Fundamental Research Funds for Central Universities
Zitieren
APA
Du, X., Guo, S., Mu, X., Mei, S., Yang, R., Zhang, H., Jiang, C., & Zhang, J. (2024). Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice. IUBMB Life. https://doi.org/10.1002/iub.2857
Vancouver
Du X, Guo S, Mu X, Mei S, Yang R, Zhang H, et al. Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice. IUBMB Life. 2024. doi:10.1002/iub.2857
BibTeX
@article{Du2024,
author = {Du, Xinyi and Guo, Shaoting and Mu, Xuemeng and Mei, Song and Yang, Rui and Zhang, Hengyan and Jiang, Chengyu and Zhang, Jia},
title = {Bencaosome [16:0 Lyso PA + XLGB28 ‐ sRNA ] improves osteoporosis by simultaneously promoting osteogenesis and inhibiting osteoclastogenesis in mice},
journal = {IUBMB Life},
year = {2024},
doi = {10.1002/iub.2857}
}
EUVIMED